Stephen M. Kanovsky
Independent DirectorMr. Stephen M. Kanovsky, also known as Steve, serves as Director at NeoGenomics Laboratories, Inc. since 2021. He is General Counsel of Global Innovation of GE Healthcare, a business unit of General Electric. Mr. Kanovsky has legal experience in the global life sciences and biotechnology industry. He served as an Executive Vice President and General Counsel at Archimedes Pharma Limited. Mr. Kanovsky joined Archimedes Pharma in June 2010. He served as the Senior Vice President, Legal and Government Affairs with Abraxis BioScience. From 1998 to 2009, he held various legal roles with Sanofi-Aventis US and its predecessors, including Associate General Counsel/Head, US Litigation and Investigations and US Corporate Compliance Officer. Prior to Sanofi-Aventis, he had a general civil litigation practice as a litigation associate with Drinker Biddle LLP in Princeton New Jersey. He also worked at Merck in several capacities, including basic research, regulatory affairs and project management. He serves as an Independent Director at NeoGenomics, Inc. since July 19, 2017. He is an Adjunct Professor at the St. Joseph's Haub School of Business. He subsequently graduated from Temple University School of Pharmacy with a master degree in Pharmacology and Temple University School of Law with a juris doctorate degree. Mr. Kanovsky also holds a master degree in business administration from Saint Joseph University Haub School of Business.
Positions
- Company NameNeoGenomics, Inc.Stock CodeNEOPositionIndependent DirectorColleagues
- APAnthony P. ZookCEO & Director
- LALynn A. TetraultIndependent Chair of the Board
- WSWarren StonePresident & COO
- EAElizabeth A. FloegelChief Digital & Information Officer
- GPGary PassmanChief People & Culture Officer
- AJAbhishek JainExecutive VP & CFO
- ALAlison L. HannahMember of Scientific Advisory Board
- MAMichael A. KellyIndependent Director
